SIM
ANIP icon

Spark Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Spark Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,000
Closed -$206K – 666
2014
Q2 		$206K Sell
6,000
-43,500
-88% -$1.36M 0.03% 489
2014
Q1 		$1.55M Buy
+49,500
New +$1.31M 0.24% 126

Other funds holding ANIP

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.71B AUM 65.19% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Spark Investment Management's ANIP Position: Q3 2014 in Review

Spark Investment Management sold out of ANI Pharmaceuticals (ANIP) in Q3 2014, closing a stake of 6,000 shares — an estimated $206K sold.

Spark Investment Management first reported a position in ANIP in Q1 2014 and held it in 2 quarters. The position peaked at $1.55M in Q1 2014. 72 funds tracked by Wall St. Rank hold ANIP as of Q3 2014.

  • Spark Investment Management reported no remaining ANI Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Spark Investment Management sold 6,000 ANI Pharmaceuticals shares in Q3 2014, an estimated $206K.
  • Spark Investment Management first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • Spark Investment Management's ANI Pharmaceuticals position peaked at $1.55M in Q1 2014.
  • 72 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2014.

Based on Spark Investment Management's 13F filing for Q3 2014, filed 13 Nov 2014.